Pages that link to "Q29547696"
Jump to navigation
Jump to search
The following pages link to Clonal evolution in cancer (Q29547696):
Displaying 50 items.
- Evaluation of clonal origin of malignant mesothelioma (Q21146661) (← links)
- Sequencing pools of individuals — mining genome-wide polymorphism data without big funding (Q22121997) (← links)
- Intratumor heterogeneity: evolution through space and time (Q24598678) (← links)
- Genetic Heterogeneity and Clonal Evolution of Tumor Cells and their Impact on Precision Cancer Medicine (Q24604479) (← links)
- Stress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer? (Q26739748) (← links)
- Stem cell technology in breast cancer: current status and potential applications (Q26746223) (← links)
- Genetic profiling of intrahepatic cholangiocarcinoma and its clinical implication in targeted therapy (Q26751655) (← links)
- Clonal origin and spread of metastatic prostate cancer (Q26752873) (← links)
- Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination (Q26765345) (← links)
- Stem Cell Modeling of Core Binding Factor Acute Myeloid Leukemia (Q26765858) (← links)
- Cancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesis (Q26766386) (← links)
- Experimental evolution in biofilm populations. (Q26768691) (← links)
- Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment (Q26769963) (← links)
- Cancer Metabolism: A Modeling Perspective (Q26770819) (← links)
- Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence (Q26774502) (← links)
- Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials (Q26776394) (← links)
- Characterization of DNA Methylation in Circulating Tumor Cells (Q26778427) (← links)
- Genomics of Cancer and a New Era for Cancer Prevention (Q26779113) (← links)
- Is lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells? (Q26779702) (← links)
- Cancer stem cell targeted therapy: progress amid controversies. (Q26779931) (← links)
- Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us? (Q26781271) (← links)
- Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives (Q26781613) (← links)
- The influence of subclonal resistance mutations on targeted cancer therapy (Q26781693) (← links)
- Cancer classification in the genomic era: five contemporary problems (Q26781783) (← links)
- Stem cells in genetically-engineered mouse models of prostate cancer (Q26784057) (← links)
- Challenges of deciphering gastric cancer heterogeneity (Q26784448) (← links)
- Biological features and biomarkers in hepatocellular carcinoma (Q26799462) (← links)
- Protecting the normal in order to better kill the cancer (Q26801291) (← links)
- Evolutionary determinants of cancer (Q26801710) (← links)
- The 3' to 5' Exoribonuclease DIS3: From Structure and Mechanisms to Biological Functions and Role in Human Disease (Q26801730) (← links)
- The evolving contribution of hematopoietic progenitor cells to lymphomagenesis (Q26823905) (← links)
- The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? (Q26824147) (← links)
- Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine (Q26825186) (← links)
- Next-generation pathology--surveillance of tumor microecology (Q26828839) (← links)
- Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer? (Q26828997) (← links)
- Cancer heterogeneity--a multifaceted view (Q26829228) (← links)
- Heterogeneity and targeting of pancreatic cancer stem cells (Q26851734) (← links)
- Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies (Q26852049) (← links)
- Glioblastoma cancer stem cells: Biomarker and therapeutic advances (Q26859782) (← links)
- An expanding universe of the non-coding genome in cancer biology (Q26865920) (← links)
- Tumour heterogeneity and the evolution of polyclonal drug resistance (Q26866803) (← links)
- Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis (Q26991480) (← links)
- How animal models of leukaemias have already benefited patients (Q26997702) (← links)
- Microenvironmental control of stem cell fate in intestinal homeostasis and disease (Q26999226) (← links)
- Molecular imaging of breast cancer: present and future directions (Q26999488) (← links)
- Breast cancer intra-tumor heterogeneity (Q27000086) (← links)
- Cancer evolution: mathematical models and computational inference (Q27002537) (← links)
- Advances and applications of single-cell sequencing technologies (Q27004390) (← links)
- Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers (Q27006938) (← links)
- Cellular hyperproliferation and cancer as evolutionary variables (Q27008923) (← links)